Lucas Opazo-Ríos

1.3k total citations · 2 hit papers
20 papers, 1.0k citations indexed

About

Lucas Opazo-Ríos is a scholar working on Immunology, Molecular Biology and Nephrology. According to data from OpenAlex, Lucas Opazo-Ríos has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Nephrology. Recurrent topics in Lucas Opazo-Ríos's work include Advanced Glycation End Products research (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Lucas Opazo-Ríos is often cited by papers focused on Advanced Glycation End Products research (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Lucas Opazo-Ríos collaborates with scholars based in Spain, Chile and Germany. Lucas Opazo-Ríos's co-authors include Jesús Egido, Juan Antonio Moreno, Carmen Gómez‐Guerrero, Sebastián Mas, Sergio Mezzano, Gema Marín‐Royo, Ana B. Sanz, Sandra Rayego‐Mateos, Cristina García‐Caballero and Cristina Vázquez‐Carballo and has published in prestigious journals such as Free Radical Biology and Medicine, International Journal of Molecular Sciences and The Journal of Pathology.

In The Last Decade

Lucas Opazo-Ríos

19 papers receiving 1.0k citations

Hit Papers

Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic ... 2020 2026 2022 2024 2020 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
    2020 251 citations Lucas Opazo-Ríos, Sebastián Mas et al. International Journal of Molecular Sciences profile →
  2. Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
    2020 232 citations Sandra Rayego‐Mateos, José Luis Morgado‐Pascual et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucas Opazo-Ríos Spain 12 347 291 200 169 155 20 1.0k
Xiangming Qi China 21 416 1.2× 313 1.1× 114 0.6× 208 1.2× 127 0.8× 50 1.1k
Chunling Huang China 21 565 1.6× 200 0.7× 132 0.7× 91 0.5× 162 1.0× 56 1.1k
Shan Song China 19 682 2.0× 232 0.8× 141 0.7× 147 0.9× 160 1.0× 33 1.2k
Bryna S.M. Chow Australia 10 326 0.9× 276 0.9× 216 1.1× 156 0.9× 82 0.5× 12 1.0k
Xiangdong Yang China 18 297 0.9× 251 0.9× 61 0.3× 176 1.0× 114 0.7× 57 975
Rongshuang Huang China 18 572 1.6× 447 1.5× 81 0.4× 162 1.0× 168 1.1× 34 1.3k
Yunman Wang China 20 421 1.2× 365 1.3× 72 0.4× 72 0.4× 158 1.0× 36 1.1k
Sih Min Tan Australia 17 547 1.6× 198 0.7× 183 0.9× 152 0.9× 102 0.7× 32 1.2k
Juhong Yang China 17 406 1.2× 178 0.6× 238 1.2× 76 0.4× 134 0.9× 57 1.0k
Xiongzhong Ruan China 22 609 1.8× 217 0.7× 179 0.9× 130 0.8× 268 1.7× 45 1.3k

Countries citing papers authored by Lucas Opazo-Ríos

Since Specialization
Citations

This map shows the geographic impact of Lucas Opazo-Ríos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas Opazo-Ríos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas Opazo-Ríos more than expected).

Fields of papers citing papers by Lucas Opazo-Ríos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucas Opazo-Ríos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas Opazo-Ríos. The network helps show where Lucas Opazo-Ríos may publish in the future.

Co-authorship network of co-authors of Lucas Opazo-Ríos

This figure shows the co-authorship network connecting the top 25 collaborators of Lucas Opazo-Ríos. A scholar is included among the top collaborators of Lucas Opazo-Ríos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucas Opazo-Ríos. Lucas Opazo-Ríos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tejera‐Muñoz, Antonio, Vanessa Marchant, Lucía Tejedor-Santamaria, et al.. (2025). The Role of miR-802 in Diabetic Kidney Disease: Diagnostic and Therapeutic Insights. International Journal of Molecular Sciences. 26(12). 5474–5474.
2.
Opazo-Ríos, Lucas, Iolanda Lázaro, Juan Antonio Moreno, et al.. (2024). Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences. 25(5). 2961–2961. 22 indexed citations
3.
García‐Caballero, Cristina, Melania Guerrero‐Hue, José M. Villalba, et al.. (2024). Nox4 is involved in acute kidney injury associated to intravascular hemolysis. Free Radical Biology and Medicine. 225. 430–444. 4 indexed citations
4.
Rayego‐Mateos, Sandra, José Luis Morgado‐Pascual, Cristina García‐Caballero, et al.. (2023). Intravascular hemolysis triggers NAFLD characterized by a deregulation of lipid metabolism and lipophagy blockade. The Journal of Pathology. 261(2). 169–183. 3 indexed citations
5.
Opazo-Ríos, Lucas, Antonio Tejera‐Muñoz, Vanessa Marchant, et al.. (2022). Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice. Frontiers in Pharmacology. 13. 778776–778776. 9 indexed citations
6.
Opazo-Ríos, Lucas, Iolanda Lázaro, Aleix Sala‐Vila, et al.. (2022). Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice. International Journal of Molecular Sciences. 23(7). 3965–3965. 12 indexed citations
7.
Vázquez‐Carballo, Cristina, Carmen Herencia, Melania Guerrero‐Hue, et al.. (2022). Role of Toll‐like receptor 4 in intravascular hemolysis‐mediated injury. The Journal of Pathology. 258(3). 236–249. 9 indexed citations
8.
Opazo-Ríos, Lucas, Gema Marín‐Royo, Macarena Orejudo, et al.. (2022). The Synthetic Flavonoid Hidrosmin Improves Endothelial Dysfunction and Atherosclerotic Lesions in Diabetic Mice. Antioxidants. 11(12). 2499–2499. 4 indexed citations
9.
Opazo-Ríos, Lucas, et al.. (2021). Recommendations for implementation of physical training guidelines for patients undergoing chronic hemodialysis. Repositorio Institucional de la Universidad de Alicante (Universidad de Alicante). 1 indexed citations
10.
Vázquez‐Carballo, Cristina, Melania Guerrero‐Hue, Cristina García‐Caballero, et al.. (2021). Toll-Like Receptors in Acute Kidney Injury. International Journal of Molecular Sciences. 22(2). 816–816. 59 indexed citations
11.
Marín‐Royo, Gema, Macarena Orejudo, Lucas Opazo-Ríos, et al.. (2021). Nephroprotective Effects of Synthetic Flavonoid Hidrosmin in Experimental Diabetic Nephropathy. Antioxidants. 10(12). 1920–1920. 6 indexed citations
12.
Guerrero‐Hue, Melania, Sandra Rayego‐Mateos, Cristina Vázquez‐Carballo, et al.. (2020). Protective Role of Nrf2 in Renal Disease. Antioxidants. 10(1). 39–39. 83 indexed citations
13.
Opazo-Ríos, Lucas, Sebastián Mas, Gema Marín‐Royo, et al.. (2020). Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities. International Journal of Molecular Sciences. 21(7). 2632–2632. 251 indexed citations breakdown →
14.
Rayego‐Mateos, Sandra, José Luis Morgado‐Pascual, Lucas Opazo-Ríos, et al.. (2020). Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy. International Journal of Molecular Sciences. 21(11). 3798–3798. 232 indexed citations breakdown →
15.
Opazo-Ríos, Lucas, Laura Lopez‐Sanz, Daniel Carpio, et al.. (2020). Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy. International Journal of Molecular Sciences. 21(12). 4225–4225. 15 indexed citations
16.
Opazo-Ríos, Lucas, Raúl R. Rodrigues-Díez, Daniel Carpio, et al.. (2020). Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes. BMJ Open Diabetes Research & Care. 8(1). e001242–e001242. 19 indexed citations
17.
Lavoz, Carolina, Sandra Rayego‐Mateos, Macarena Orejudo, et al.. (2020). Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?. Journal of Clinical Medicine. 9(1). 272–272. 34 indexed citations
18.
Marín‐Royo, Gema, et al.. (2020). The Coming Age of Flavonoids in the Treatment of Diabetic Complications. Journal of Clinical Medicine. 9(2). 346–346. 79 indexed citations
19.
Moreno, Juan Antonio, Carmen Gómez‐Guerrero, Sebastián Mas, et al.. (2018). Targeting inflammation in diabetic nephropathy: a tale of hope. Expert Opinion on Investigational Drugs. 27(11). 917–930. 142 indexed citations
20.
Carretta, María Daniella, Lucas Opazo-Ríos, María A. Hidalgo, et al.. (2016). Butyric acid stimulates bovine neutrophil functions and potentiates the effect of platelet activating factor. Veterinary Immunology and Immunopathology. 176. 18–27. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangming Qi Breakdown of academic impact, for papers by Chunling Huang Breakdown of academic impact, for papers by Shan Song Breakdown of academic impact, for papers by Bryna S.M. Chow Breakdown of academic impact, for papers by Xiangdong Yang Breakdown of academic impact, for papers by Rongshuang Huang Breakdown of academic impact, for papers by Yunman Wang Breakdown of academic impact, for papers by Sih Min Tan Breakdown of academic impact, for papers by Juhong Yang Breakdown of academic impact, for papers by Xiongzhong Ruan
Rankless by CCL
2026